Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation. - Wikidata - wikimedia - TriplyDB

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

http://www.wikidata.org/entity/Q45104259

about

Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery.Mutations in cardiovascular connexin genes.Structural determinants and proliferative consequences of connexin 37 hemichannel function in insulinoma cells.Sidestream smoke exposure increases the susceptibility of airway epithelia to adenoviral infection A functional channel is necessary for growth suppression by Cx37.Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax Cx40 is required for, and cx37 limits, postischemic hindlimb perfusion, survival and recovery Inducible coexpression of connexin37 or connexin40 with connexin43 selectively affects intercellular molecular transfer.Carboxy terminus and pore-forming domain properties specific to Cx37 are necessary for Cx37-mediated suppression of insulinoma cell proliferation.High bone mass in mice lacking Cx37 because of defective osteoclast differentiation.Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia.Regulation of connexin- and pannexin-based channels by post-translational modifications.Connexins in respiratory and gastrointestinal mucosal immunity.Connexins: junctional and non-junctional modulators of proliferation.Regulation of Cx37 channel and growth suppressive properties by phosphorylation.Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification.Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.Human venous valve disease caused by mutations in FOXC2 and GJC2.Early markers for myocardial ischemia and sudden cardiac death.Connexins: Synthesis, Post-Translational Modifications, and Trafficking in Health and Disease.Connexins and Pannexins in Vascular Function and Disease

P2860

Q33998452-D114D318-8A3E-46E1-9451-22A93019956F Q34426537-F7C906EE-7C0C-44EF-A46A-8109370062F7 Q34430943-6879154A-0C71-4152-9FAC-9B0F4312A791 Q34482900-22348FEC-1441-4CB5-9848-17F2323ECA96 Q35071530-9B682041-7605-4694-A2F6-8D69A92D8122 Q35099297-EE03987A-9624-49DB-AAD7-169F3F293535 Q35564784-61E2B577-13B9-4152-B8E5-6BA36373A71F Q36410895-D1DD22F1-2B93-4875-9366-7F539253C934 Q37439721-B13F0C1A-A05E-44DE-8193-53F0B3B70C90 Q37653316-366C3923-3C12-4292-AA25-69037721365A Q38026529-8378C813-BD84-4B3D-8E2E-218CA0D91B8D Q38110305-7C7C6258-C084-4094-A305-3C4E4169167C Q38196155-08B55C5D-2049-4872-BA73-0A79382ACADF Q38303074-7CF91AB5-BA6A-49CB-9A3C-7A8A2414EB95 Q38619204-06F790A9-DADB-4CE8-B3C3-AF73D2586CBE Q47102212-3DAA228D-1723-4E2D-93EC-59BD3A1F9055 Q47770967-8CDF0D18-6002-454C-8CDE-D54C9B0DDCC2 Q48099591-28AE1560-CD30-4980-97C6-981C6D9DA061 Q51653921-F222D850-0829-4697-9C01-798D152C0F17 Q52716310-AC48E012-759C-4FA2-BEB9-4EBA92285E31 Q56363256-6B0EC386-D0CF-4DF9-BC17-63CE953E79E7

P2860

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

http://www.wikidata.org/entity/Q45104259

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

@en

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

@nl

type

label

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

@en

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

@nl

prefLabel

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

@en

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

@nl

P1433

Q45104259-756DBF51-0C80-45A7-86ED-0EDCE7E7A92C

P1476

Q45104259-9C149797-2691-4DB0-804E-381C4FE88F62

P2093

Q45104259-0F2327BC-BA69-4688-A651-BF9902CB9AAA

Q45104259-2DECA0BF-6C7D-4BA3-A842-F90835992C93

Q45104259-7F6ECEE1-385B-4209-9B63-57CCBBE57CAD

Q45104259-A71ECAB7-6FDF-4B57-B22C-AEC2B11AA73F

Q45104259-CA8624EE-D538-48F6-BD68-A3A441B0EF6B

Q45104259-D9F48013-37A2-4C3A-9CB2-179A8650F284

Q45104259-FB438568-4731-4C98-96A0-95E9E8D3DC07

P2860

Q45104259-01CE375E-30D6-4F78-A06B-472A94BEF497

Q45104259-17AB46A6-15AC-427B-8B0C-ED955C084642

Q45104259-19296D0B-B9CC-4704-A83A-F3D878648B5E

Q45104259-205E483D-6811-4E33-AFB5-FA091CF976DC

Q45104259-25B0E502-BDC0-4365-A7E6-80A669B82C1D

Q45104259-37090F1B-94D7-4862-BE1B-E34F86582569

Q45104259-39A29235-63B8-4711-9D44-54ECC9D42BAD

Q45104259-3D0AFD10-D2F9-4829-9491-A0E4A9DFFE68

Q45104259-451BB051-B5CE-4A80-B67E-5DC9376DB61E

Q45104259-523CD392-B30D-43D5-8552-0FD2178FE822

P304

Q45104259-28C0DA99-2BE3-4453-BFE7-921BC71320D4

P31

Q45104259-02EE21E5-7C01-405E-8BCB-A8743E839988

P356

Q45104259-8CC7E5F3-3E20-4134-AF76-B7FB264788DB

P407

Q45104259-70ACFB6A-CDEB-4964-BF4F-BF590F44294E

P433

Q45104259-4090A4D2-DE5C-4118-9970-AB1A8D8F23E1

P478

Q45104259-8E92F024-49A2-4062-BDDA-A7D3B6A76020

P50

Q45104259-11D7D2C7-217D-4C58-BA2B-DF271A1D779C

Q45104259-8C0ECE51-973C-4E65-93F8-9B9D92F33F12

Q45104259-941E514A-8D50-4E6D-A09D-A2EF93FDD062

P577

Q45104259-3E076DE0-3EC6-4A0F-81E4-7DDA83E9EAA7

P5875

Q45104259-5B9B1FA2-B1D0-448F-B185-FA353E01FDF1

P698

Q45104259-ACECBEBE-3F32-433F-ACEC-61332D081EAE

P356

P1433

P1476

Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.

@en

P2093

Alexandra Chassot

http://www.w3.org/2001/XMLSchema#string

Angela Roatti

http://www.w3.org/2001/XMLSchema#string

Anna Pfenniger

http://www.w3.org/2001/XMLSchema#string

Brenda R Kwak

http://www.w3.org/2001/XMLSchema#string

Esther Sutter

http://www.w3.org/2001/XMLSchema#string

Isabelle Roth

http://www.w3.org/2001/XMLSchema#string

Katia Galan

http://www.w3.org/2001/XMLSchema#string

P2860

Glycogen synthase kinase 3: more than a namesake

GSK-3: tricks of the trade for a multi-tasking kinase

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin

Human hemangiosarcomas have a common polymorphism but no mutations in the connexin37 gene

Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP

Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes

Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence

Connexins in vascular physiology and pathology.

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

P304

1922-1931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGQ170

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Laurent Burnier

P577

2010-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45640426

http://www.w3.org/2001/XMLSchema#string

P698

20705954

http://www.w3.org/2001/XMLSchema#string